×

Cochlear Limited

We help people hear and be heard. We empower people to connect with others and live a full life.

We help transform the way people understand and treat hearing loss.

We innovate and bring to market a range of implantable hearing solutions that deliver a lifetime of hearing outcomes.

ASX Code
COH

Sector
Health Care Equipment & Services

Website
https://www.cochlear.com/intl/home

Spotlight Videos

Analysis of oOh!media, Cochlear, Elders

April 10, 2024 - by Finance News Network

Fund Manager Chris Pedersen discusses oOh!media, Cochlear and Elders.

Watch Now

Companies immune from rate rises: Sonic Healthcare, Cochlear, Transurban

November 8, 2023 - by Finance News Network

Fund Manager Chris Pedersen discusses the RBA's rate hike, inflation, banks, dividend growth stocks, Sonic Healthcare, Transurban Group and Cochlear.

Watch Now

News

Cochlear delivers record results

August 15, 2024 - by Glenn Dyer

Hearing implant group Cochlear (ASX:COH) will reward shareholders with a sharp rise in dividend and a buyback after reporting a record result for the year to June, with total revenue exceeding $2 billion for the first time.

Read More

Cochlear surpasses expectations

February 19, 2024 - by Glenn Dyer

Earlier this month, hearing implant giant Cochlear surprised investors with a significant upgrade to revenue growth and earnings for the six months to December, along with higher guidance for the year to June 30. Today, it has followed up with the actual figures for the six months to December, along with a higher dividend.

Read More

Cochlear anticipates robust performance for 2023-24

August 15, 2023 - by Glenn Dyer

Hearing device manufacturer, Cochlear (ASX:COH), is poised for a strong performance in the fiscal year 2023-24, following a commendable performance until June.

Read More

Corporate Chatter: TWE, COH, VCX

February 15, 2023 - by Glenn Dyer

A veritable plethora of earnings reports through the ASX today, from which we have sifted those by Treasury Wine Estates, Cochlear and Vicinity Centres for your consideration.

Read More

Cochlear Hears from the ACCC on Oticon Bid

December 1, 2022 - by Glenn Dyer

The ACCC has raised what it calls "significant preliminary competition concerns" with Cochlear’s proposed $170 million acquisition of Oticon Medical.

Read More

New FDA Hearing Aid Ruling May Impact Cochlear

August 17, 2022 - by Glenn Dyer

In a move that could rattle the share price of Cochlear for a while, key US health regulators have cleared the way for hearing aids to be sold over the counter from the middle of October.

Read More

Elective Surgery Restrictions Hurt Cochlear

February 22, 2022 - by Glenn Dyer

Cochlear has warned investors it expects the continuing restrictions on elective surgeries here and offshore will see slower growth in hearing implant sales for the year to June.

Read More

COH – Morgans rates the stock as Hold

August 23, 2021 - by Broker News

While FY21 results were below consensus, they were in-line with Morgans expectations while guidance points to continued momentum. The Hold rating is unchanged and the target price increases to $214.5 from $201.1.

Read More

COH – Credit Suisse rates the stock as Neutral

May 21, 2021 - by Broker News

The Neutral rating is unchanged and the target falls to $225 from $230.

Read More

Turnaround in Place at Cochlear

February 19, 2021 - by Glenn Dyer

Hearing implant maker, Cochlear is making a return to paying dividends after the impact of COVID, the pandemic and social distancing rules damaged its 2020 finances.

Read More